Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn's Disease Exhibit Similar Pharmacokinetics.

Ruben J ColmanStephanie A VuijkRon A A MathôtJohan Van LimbergenMaria M E JongsmaMarco W J SchreursPhillip Paul MinarLissy de RidderGeert R A M D'Haens

Published in: Inflammatory bowel diseases (2024)

This study suggests that there are no PK differences (TLs and CL) between combo and mono therapy in pediatric CD patients who started IFX.

Keyphrases

combination therapy
randomized controlled trial
stem cells
young adults
open label
smoking cessation